The lab is developing a bispecific antibody for cancer therapy. 实验室正在开发一种用于癌症治疗的双特异性抗体。
Bispecific Tcell engagers can redirect T cells to recognize and kill tumor cells that would otherwise evade immune detection. 双特异性T细胞连接器可以引导T细胞识别并杀死原本可能逃避免疫监测的肿瘤细胞。